Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
58
VOR Quote, Financials, Valuation and Earnings
Last price:
$2.38
Seasonality move
:
-26.76%
Day range:
$1.92 - $2.37
52-week range:
$0.13 - $3.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.01x
Volume:
12.5M
Avg. volume:
32.5M
1-year change:
109.9%
Market cap:
$264.9M
Revenue:
--
EPS (TTM):
-$1.51
Earnings Data
Next earnings date for VOR
Aug 08
2025
Most recent earnings per share
-$0.26
Missed by $0.05
(May 14/2025)
Consensus Estimate
-$0.21
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VOR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.10 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.59 | -- |
| 05/14/2025 | Q1 | -- | -- | -$0.26 | -$0.21 | -$0.05 |
| 03/20/2025 | Q4 | -- | -- | -$0.44 | -$0.31 | -$0.13 |
| 11/07/2024 | Q3 | -- | -- | -$0.40 | -$0.40 | $0.00 |
| 08/08/2024 | Q2 | -- | -- | -$0.41 | -$0.41 | $0.00 |
| 05/09/2024 | Q1 | -- | -- | -$0.45 | -$0.38 | -$0.07 |
| 03/20/2024 | Q4 | -- | -- | -$0.38 | -$0.50 | $0.12 |
| 11/07/2023 | Q3 | -- | -- | -$0.49 | -$0.46 | -$0.03 |
| 08/10/2023 | Q2 | -- | -- | -$0.45 | -$0.42 | -$0.03 |
| 05/11/2023 | Q1 | -- | -- | -$0.43 | -- | -- |
| 03/23/2023 | Q4 | -- | -- | -$0.52 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$0.63 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$0.58 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.61 | -- | -- |
| 03/14/2022 | Q4 | -- | -- | -$0.48 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.50 | -- | -- |
| 08/09/2021 | Q2 | -- | -- | -$0.50 | -- | -- |
| 05/06/2021 | Q1 | -- | -- | -$0.67 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.51 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$1.14 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.73 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.70 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.36 | -- | -- |
Vor Biopharma Earnings Questions
-
How Much did Vor Biopharma Generate in Revenue Last Quarter?
Vor Biopharma reported -- worth of top line sales in its most recent quarter.
-
Did Vor Biopharma Beat Earnings Last Quarter?
Vor Biopharma announced earnings per share of -$0.26 which represents a miss of analyst forecast a -$0.21 per share.
-
Is Vor Biopharma Profitable?
Vor Biopharma reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Vor Biopharma EPS Next Year?
Vor Biopharma's earnings are forecast to decrease from -$1.70 per share to -$1.46 per share next year representing a decrease of -62.21%.
-
When is Vor Biopharma's Earnings Date?
Vor Biopharma's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
